Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
about
Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta inductionInvolvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cellsPlasminogen activator inhibitor-1 and the kidney.Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillationConnective tissue metabolism and gingival overgrowth.Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis.An emerging role for calcineurin Aalpha in the development and function of the kidney.Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damageTherapeutic potential of TGF-beta inhibition in chronic renal failure.Pirfenidone is renoprotective in diabetic kidney disease.Acute kidney injury following HCT: incidence, risk factors and outcome.Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation.Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model.TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.NFATc is required for TGFbeta-mediated transcriptional regulation of fibronectin.Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury.Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation.Failure of cyclosporin A to induce transforming growth factor beta (TGF-beta) synthesis in activated peripheral blood lymphocytes.TGF-beta impairs renal autoregulation via generation of ROS.Influence of pretransplant IFN-alpha therapy on interstitial fibrosis in renal allografts with hepatitis C virus infection.Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats.The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy.Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.Gut microbiota-derived short-chain fatty acids and kidney diseases.Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats.Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis.Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal.
P2860
Q28478432-8034E5E2-F7C6-4156-BE85-F68FE5C87D08Q28574951-63DB5FAD-CCFA-4591-98F1-E263EA6A0397Q33960082-1754B907-47C7-41F0-872D-DBB95F7E8989Q34611013-B5232DFE-8E47-409E-8E37-08AC935A93EBQ35798724-0251FE70-1457-466E-8F26-D59AC7202032Q36095003-B7DD96FB-D9F5-4903-8D9F-FEDE026049C3Q36417660-4BD6D59E-F9B9-46ED-990F-3B830084D00EQ36536931-B4B0A894-4B13-4521-B8F7-BFFCA94A8737Q36739752-D919C019-3A30-4025-A862-02BA62721A9DQ37297659-DC89CE88-2A60-41FF-9DFD-2E400E45FEE8Q37850680-DC3910E6-6BB0-4101-AC43-E563CFF4A0FBQ38294666-15072392-AF73-4490-862F-260F802CAF12Q39164538-74A85DD8-096F-472E-B429-3951BD1ED205Q39481525-B949607C-5A31-490A-A973-8CF725115FDDQ40089668-C0F38D25-1569-4A3B-9D72-73B0531B1534Q40666037-1DB09311-A3B6-4583-B65F-988F3407B153Q44185820-158EDAAF-F7CD-4E17-B1F9-5A7CA699D28BQ44316561-035C4C8A-DD93-4445-8624-B81126C4D5F4Q45220024-EA8E05A3-B6C2-4832-B8A9-DB22DD1C182CQ45401530-6FDF3384-FB22-43F4-8675-9DD45139ADB8Q46434563-A427BCB3-AA7C-4D83-B11A-0796CCE3DD3DQ46487189-B55C5B64-A5C3-41F3-B145-8FAB15A208E1Q46845127-4CB6450D-071C-4485-B565-1964A01B5CBFQ47147649-E7A5A307-1B5C-4ED5-A0F9-CE7B1C10B168Q53670434-92E6ED58-CADF-426F-95D3-E538291FFEB8Q54239740-5BEDD7BB-E5ED-499B-90FA-15EF1D11B659Q54524082-C90E20B9-014E-4AFE-89E0-FB94B336FFEAQ55318062-DECAEFB3-ECF9-47EF-BFE0-C924C896FDF2
P2860
Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@ast
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@en
type
label
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@ast
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@en
prefLabel
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@ast
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@en
P2093
P1433
P1476
Effect of anti-transforming gr ...... ine-induced renal dysfunction.
@en
P2093
Burke JF Jr
McGowan TA
P304
P356
10.1046/J.1523-1755.2001.059002498.X
P407
P577
2001-02-01T00:00:00Z
P5875
P6179
1012395040